Evidence map›Paper›PMID 34360156›Full record

ArticleInternational journal of environmental research and public health2021

COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects.

Abanoub Riad, Holger Schünemann, Sameh Attia, Tina Poklepović Peričić, Marija Franka Žuljević, Mikk Jürisson, Ruth Kalda, Katrin Lang, Sudhakar Morankar, Elias Ali Yesuf and 19 more

Registry-linked trialAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04834869 (COVID-19 Vaccines Safety Tracking), which is not on this map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04834869 recruitingnot on this map

COVID-19 Vaccines Safety Tracking: Global Consortium Study

TypeobservationalSponsorMasaryk UniversityRan2021 to 2026Enrolled30,000ConditionsAdverse Reaction to Vaccine, COVID19 VaccineArmsBNT162b2, mRNA-1273, AZD1222, CoronaVac, Sinopharm
3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Effectiveness of COVID-19 vaccines on hospitalization and death in Guilan, Iran: a test-negative case-control study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Abanoub RiadCzech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Holger SchünemannDepartment of Health Research Methods, Evidence, and Impact, McMaster University Health Sciences Centre, Room 2C16, 1280 Main Street West, Hamilton, ON L8N 4K1, Canada.
Sameh AttiaDepartment of Oral and Maxillofacial Surgery, Justus-Liebig-University, Klinikstrasse 33, 35392 Giessen, Germany.ORCID 0000-0002-9174-6435
Tina Poklepović PeričićDepartment of Research in Biomedicine and Health, University of Split School of Medicine, Šoltanska 2, 21000 Split, Croatia.
Marija Franka ŽuljevićDepartment of Medical Humanities, University of Split School of Medicine, Šoltanska 2, 21000 Split, Croatia.
Mikk JürissonDepartment of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411 Tartu, Estonia.ORCID 0000-0002-4487-7045
Ruth KaldaDepartment of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411 Tartu, Estonia.
Katrin LangDepartment of Family Medicine and Public Health, University of Tartu, Ravila 19, 50411 Tartu, Estonia.
Sudhakar MorankarFaculty of Public Health, Institute of Health, Jimma University, Aba Jifar 1 Street, 378 Jimma, Ethiopia.
Elias Ali YesufFaculty of Public Health, Institute of Health, Jimma University, Aba Jifar 1 Street, 378 Jimma, Ethiopia.ORCID 0000-0003-0281-5564
Mohamed MekhemarClinic for Conservative Dentistry and Periodontology, School of Dental Medicine, Kiel University, Arnold-Heller-Str. 3, Haus B, 24105 Kiel, Germany.ORCID 0000-0003-4294-757X
Anthony Danso-AppiahDepartment of Epidemiology and Disease Control, School of Public Health, University of Ghana, Accra LG 25, Ghana.ORCID 0000-0003-1747-0060
Ahmad Sofi-MahmudiCochrane Iran Associate Centre, National Institute for Medical Research Development, Tehran 16846, Iran.ORCID 0000-0001-6829-0823
Giordano Pérez-GaxiolaDepartment of Evidence Based Medicine, Sinaloa Pediatric Hospital, Cochrane Mexico, Calle Constitución 530, Jorge Almada, 80200 Culiacán, Mexico.
Arkadiusz DziedzicDepartment of Conservative Dentistry with Endodontics, Medical University of Silesia, 40-055 Katowice, Poland.ORCID 0000-0003-0022-8382
João ApóstoloHealth Sciences Research Unit: Nursing, Portugal Centre for Evidence-Based Practice: JBI Centre of Excellence, Nursing School of Coimbra, 3004-011 Coimbra, Portugal.ORCID 0000-0002-3050-4264
Daniela CardosoHealth Sciences Research Unit: Nursing, Portugal Centre for Evidence-Based Practice: JBI Centre of Excellence, Nursing School of Coimbra, 3004-011 Coimbra, Portugal.ORCID 0000-0002-1425-885X
Janja MarcFaculty of Pharmacy, University of Ljubljana, Aškerčeva Cesta 7, 1000 Ljubljana, Slovenia.
Mayte Moreno-CasbasNursing and Healthcare Research Unit (Investén-isciii), Instituto de Salud Carlos III, 28029 Madrid, Spain.ORCID 0000-0001-9061-4628
Charles Shey WiysongeCochrane South Africa, South African Medical Research Council, Cape Town 7501, South Africa.ORCID 0000-0002-1273-4779
Amir QaseemAmerican College of Physicians, 190 N Independence Mall W, Philadelphia, PA 19106, USA.
Anna GryschekDepartment of Nursing in Collective Health, School of Nursing, University of São Paulo, São Paulo 419, Brazil.ORCID 0000-0001-5012-5977
Ivana TadićDepartment of Social Pharmacy and Pharmaceutical Legislation, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.
Salman HussainCzech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.ORCID 0000-0002-1691-8428
Mohammed Ahmed KhanSchool of Pharmaceutical Education and Research, Jamia Hamdard, Hamdard Nagar, New Delhi 110062, India.
Jitka KlugarovaCzech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Andrea PokornaCzech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.ORCID 0000-0002-1305-6455
Michal KoščíkDepartment of Public Health, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.ORCID 0000-0002-9243-6391
Miloslav KlugarCzech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.ORCID 0000-0002-2804-7295

Funding

Masaryk University MUNI/A/1608/2020Masaryk University MUNI/IGA/1543/2020
6 · The paper itself

Abstract

backgroundCoronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally.

methodsA multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses' side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869.

conclusionsCoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.

Indexed as

COVID-19VaccinesCOVID-19 VaccinesCross-Sectional StudiesHumansProspective StudiesSARS-CoV-2Watchful WaitingCOVID-19 VaccinesVaccinescohort studiesCOVID-19cross-sectional studiesdrug-related side effects and adverse reactionshealth personnelmass vaccinationprevalence

Identifiers

PMID34360156
PMCPMC8345554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.